26 October 2020 Scorpion Therapeutics Launches with $108 Million to Advance Precision Oncology 2.0 read more
16 October 2020 Praxis Precision Medicines Announces Pricing of Upsized Initial Public Offering read more
14 October 2020 Kronos Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares read more
6 October 2020 Neogene Therapeutics Appoints Former Roche Chairman and Chief Executive Officer Franz B. Humer, Ph.D., as Executive Chairman of Board of Directors read more
